Eventide Asset Management - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 142 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$58,810,315
+4.0%
2,631,334
+0.0%
1.06%
+10.6%
Q2 2023$56,545,713
-10.4%
2,631,257
+0.0%
0.96%
-17.4%
Q1 2023$63,096,987
+3.4%
2,630,137
+0.0%
1.16%
-3.7%
Q4 2022$61,006,558
+44.8%
2,629,5930.0%1.20%
+45.1%
Q3 2022$42,126,000
-9.6%
2,629,5930.0%0.83%
-16.9%
Q2 2022$46,596,000
-13.0%
2,629,5930.0%1.00%
+18.8%
Q1 2022$53,539,000
+9.0%
2,629,5930.0%0.84%
+33.6%
Q4 2021$49,121,000
-5.4%
2,629,5930.0%0.63%
-8.2%
Q3 2021$51,908,000
-16.5%
2,629,5930.0%0.68%
-18.1%
Q2 2021$62,164,000
+8.0%
2,629,593
+8.3%
0.84%
-2.1%
Q1 2021$57,543,000
+18.3%
2,427,9760.0%0.85%
+14.3%
Q4 2020$48,632,000
-3.8%
2,427,9760.0%0.75%
-24.6%
Q3 2020$50,550,000
+19.0%
2,427,9760.0%0.99%
+7.1%
Q2 2020$42,490,000
+7.2%
2,427,9760.0%0.92%
-28.0%
Q1 2020$39,649,000
-20.7%
2,427,9760.0%1.28%
-8.8%
Q4 2019$49,968,000
+79.3%
2,427,9760.0%1.41%
+52.9%
Q3 2019$27,873,000
-12.7%
2,427,9760.0%0.92%
-5.1%
Q2 2019$31,928,000
-4.5%
2,427,976
+10.0%
0.97%
-15.6%
Q1 2019$33,423,000
-11.8%
2,207,6100.0%1.15%
-31.5%
Q4 2018$37,905,000
+16.5%
2,207,6100.0%1.68%
+40.4%
Q3 2018$32,540,000
-38.2%
2,207,6100.0%1.20%
-45.3%
Q2 2018$52,651,000
-6.7%
2,207,6100.0%2.18%
-17.3%
Q1 2018$56,404,000
+38.4%
2,207,6100.0%2.64%
+24.3%
Q4 2017$40,752,000
+76.0%
2,207,6100.0%2.12%
+61.9%
Q3 2017$23,158,000
-16.1%
2,207,6100.0%1.31%
-23.7%
Q2 2017$27,617,000
+27.5%
2,207,610
+2.5%
1.72%
+19.9%
Q1 2017$21,665,000
-33.0%
2,153,612
+3.7%
1.43%
-31.9%
Q4 2016$32,351,000
-16.4%
2,077,751
+3.4%
2.10%
-11.0%
Q3 2016$38,718,000
+67.5%
2,010,278
+3.1%
2.36%
+67.2%
Q2 2016$23,111,000
-31.7%
1,950,276
+4.6%
1.41%
-25.3%
Q1 2016$33,855,000
+15.4%
1,865,278
+74.9%
1.89%
+29.1%
Q4 2015$29,326,000
+36.0%
1,066,400
+9.3%
1.47%
+17.0%
Q3 2015$21,566,000
+62.1%
975,418
+30.8%
1.25%
+74.0%
Q2 2015$13,305,000745,8020.72%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q3 2020
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders